Tripep AB
🇸🇪Sweden
Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients
Phase 1
- Conditions
- Chronic Hepatitis C Virus Infection
- Interventions
- Drug: CHRONVAC-C®
- First Posted Date
- 2007-11-26
- Last Posted Date
- 2010-02-10
- Lead Sponsor
- Tripep AB
- Target Recruit Count
- 12
- Registration Number
- NCT00563173
- Locations
- 🇸🇪
Department of Gastroenterology and Hepatology, Karolinska University Hospital, Solna, Stockholm, Sweden
🇸🇪I73 Department of Infectious Diseases, Karolinska Institute, Karolinska University Hospital, Huddinge, Stockholm, Sweden
© Copyright 2025. All Rights Reserved by MedPath